"Parasympathomimetics" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here.
| Descriptor ID |
D010277
|
| MeSH Number(s) |
D27.505.696.663.050.675
|
| Concept/Terms |
Parasympathomimetics- Parasympathomimetics
- Parasympathomimetic Drugs
- Drugs, Parasympathomimetic
- Parasympathomimetic Agents
- Agents, Parasympathomimetic
Parasympathomimetic Effect- Parasympathomimetic Effect
- Effect, Parasympathomimetic
- Parasympathomimetic Effects
- Effects, Parasympathomimetic
|
Below are MeSH descriptors whose meaning is more general than "Parasympathomimetics".
Below are MeSH descriptors whose meaning is more specific than "Parasympathomimetics".
This graph shows the total number of publications written about "Parasympathomimetics" by people in this website by year, and whether "Parasympathomimetics" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1997 | 1 | 1 | 2 |
| 2003 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Parasympathomimetics" by people in Profiles.
-
The efficacy of galantamine in the treatment of Alzheimer's disease: comparison of patients previously treated with acetylcholinesterase inhibitors to patients with no prior exposure. Int J Geriatr Psychiatry. 2003 Apr; 18(4):292-7.
-
Signal transduction pathways in modulation of ciliary beat frequency by methacholine. Ann Otol Rhinol Laryngol. 1997 Mar; 106(3):230-6.
-
The effect of tacrine and leupeptin on the secretion of the beta-amyloid precursor protein in HeLa cells. Life Sci. 1997; 61(20):1985-92.
-
Dystonic-like reaction following cisapride therapy. J Fam Pract. 1995 Jan; 40(1):86-8.
-
Cholinergic receptor subtypes and REM sleep in animals and normal controls. Prog Brain Res. 1993; 98:379-87.
-
Cholinergic modulation of oral activity in drug-naive and chronic haloperidol-treated rats. Pharmacol Biochem Behav. 1991 May; 39(1):49-54.
-
Acetylcholine and acetylcholine receptor subtypes in REM sleep generation. Prog Brain Res. 1990; 84:407-13.
-
Effect of specific M1, M2 muscarinic receptor agonists on REM sleep generation. Brain Res. 1989 Nov 27; 503(1):128-31.
-
Continuous pontine cholinergic microinfusion via mini-pump induces sustained alterations in rapid eye movement (REM) sleep. Pharmacol Biochem Behav. 1986 Dec; 25(6):1253-61.
-
Effects of cholinergic stimulation on human esophageal peristalsis. J Appl Physiol. 1976 Jan; 40(1):40-3.